Vera Therapeutics EPS VERA

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Vera Therapeutics' earnings per share was −$5.86 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.52.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$1.52	n/a	−$5.86
Q1 FY26	Mar 31, 2026	−$1.69	n/a	−$5.54
Q4 FY25	Dec 31, 2025	−$1.39	n/a	−$4.66
Q3 FY25	Sep 30, 2025	−$1.26	n/a	−$3.99
Q2 FY25	Jun 30, 2025	−$1.20	n/a	−$3.58
Q1 FY25	Mar 31, 2025	−$0.81	n/a	−$3.00
Q4 FY24	Dec 31, 2024	−$0.72	n/a	−$2.75
Q3 FY24	Sep 30, 2024	−$0.85	n/a	−$2.61
Q2 FY24	Jun 30, 2024	−$0.62	n/a	−$2.21
Q1 FY24	Mar 31, 2024	−$0.56	n/a	−$2.05
Q4 FY23	Dec 31, 2023	−$0.58	n/a	−$2.29
Q3 FY23	Sep 30, 2023	−$0.45	n/a	−$2.88

Companies in Drug Manufacturers - General nearest Vera Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
VERAVera Therapeutics	−$5.86
HRMYHarmony Biosciences	$3.09	−0% a year
PBHPrestige Consumer Healthcare	$3.57	−16% a year
ANIPANI Pharmaceuticals	$4.70
PAHCPhibro Animal Health	$2.44	+107% a year
NRIXNurix Therapeutics	$2.31
ANABAnaptysbio	$4.57
PCRXPacira BioSciences	$0.35
OMEROmeros	$1.52
OGNOrganon	$0.77	−71% a year
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
Peer median	$2.38